TERC and Miyoshi myopathy: TERC-rs10936599-T was associated with decreased risk of developing MM (ORhomozygous = 0.55; 95% CI 0.39–0.76; P = 2.87 × 10−4), while OBFC1-rs9420907-C was associated with increased MM risk (ORheterozygous = 1.32; 95%CI 1.12–1.55; P = 7.78 × 10−4).